A Clinical Research Of The Changes Of Wendan Decoction In Treating The Allergic Bronchopulmonary Aspergillosis

Objective:The group through detect allergic bronchopulmonary aspergillosis patients who had been confirm to observe the clinical performance of allergic bonchopulmonary aspergillosis patients,and observe the clinical effection by using the Changes of Wendan Decoction and Itraconazole together.Comparison the effect by using Itraconazole Separatly.The aim of this study was to summarize a effective Chinese prescription Treatment of allergic bronchopulmonary aspergillosis.Method:Allergic bronchopulmonary aspergillosis patients borderline cases were collected from Shenzhen Hospital of Traditional Chinese Medicine,in the Out-patient and the Inpatient of the Emergency Department and the Respiratory Medicine Department,then detecting them with the method of ELISA.60 cases were screened and randomly classified routine therapeutic group and contral group.Routine therapeutic group was 30 cases, while contral group was 30cases,.Therapeutic groups was treated by the Changes of Wendan Decoction and Itraconazole together,while contral groups were treated by the Itraconazole.We progressed three months clinical observation.Result:The total evaluation on the basis of symptom,objective sign,hemogram displayed:Two groups of the age,sex,pathogenetic condition level were no difference(P＞0.05);20 cases with pant and 30 cases with cough were improving within three months in therapeutic groups,while 18 cases with pant and 20 cases with cough were improving within three months in contral groups.On the whole,the relieving time of clinical symptom of therapeutic groups was shorter than the contral groups.There was a significant statistical difference(P＜0.05).According to score standard, the two groups were no statistical difference(P＞0.05) in aspect of pant and cough.After three months,and therapeutic groups post-treatment surpassed own pre-treatment(P＜0.01).And we found score of therapeutic groups were not so many as contral groups,There was a significant statistical difference(P＜0.05):10 cases were heal,9 cases were excellence, 6 cases were utility,5 cases were ineffective in therapeutic groups,the total effective power was83.33%;but 2 cases were heal,10 cases were excellence,5 cases were utility,13 cases were ineffective in contral groups,the total effective power was 56.66%.The total effective power of therapeutic groups were obviously higher than the contral groups.There was a significant statistical difference(P＜0.01).Conclusion:According to the above results of clinical observation of treating allergic bronchopulmonary aspergillosis,we can draw the following conclusions:(1)The therapeutic group total efficiency is obviously higher than control group by using the Changes of Wendan Decoction and Itraconazole together,the total effective power was 83.33%,the therapeutic effect is positive.(2) Observe the clinical performance results show:The therapeutic group is shorter than control group in the time of asthma and cough improvement.